A month has gone by since the last earnings report for Pfizer (PFE). Shares have lost about 1.9% in that time frame, outperforming the S&P 500. Will the recent negative trend continue leading up to its next earnings release,

The surge in MRNA stock comes after some SEC filings show that company insiders bought shares worth $6 million.

The market sentiment in the next few months is likely to be quite positive for Pfizer. Read why I maintain my strong buy rating on PFE stock.

Shrewd investors know that bear markets open up great opportunities to pick up shares of excellent companies from the discount bin. It's no secret why Pfizer has not performed well recently. The company was never going to keep up those sales year in and year out.

There is no better period, given the volatility in the markets today, to rotate assets into dividend stocks, said Steven Cress, VP of Quantitative Strategy at Seeking Alpha. During Seeking Alpha’s Dividend Investing Forum virtual event,

Pfizer (PFE) may move overseas manufacturing to its existing plants in the U.S., if required, as the Trump administration threatens numerous

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility

Hyperinflation and high interest rates make dividend-paying stocks attractive. Read why PFE and BTI stocks could be great portfolio additions.

Uniondale-based McHugh Furnishings, a provider of specialty furnishings for education, healthcare, entertainment and multifamily housing, has expanded with the acquisition of an upstate furniture company.

The pharmaceutical industry is evolving continuously with the advancements in drug discovery with Artificial Intelligence (AI), propelling the industry’s growth. Amid this backdrop, quality medical stocks Pfizer (PFE),

Gene therapy stocks are transforming healthcare with revolutionary treatments. Therefore, as this sector continues to evolve, investing in gene therapy stocks like Pfizer (PFE), Sanofi (SNY), and Novartis AG (NVS) could be beneficial.

Says “I don’t think the Street” has adjusted yet and that “they should have a look on it.” The company says the rebates that Pfizer (PFE) will